Role of Lymphocytes CD4/CD8 Ratio and Immunoglobulin G Cytomegalovirus as Potential Markers for Systemic Lupus Erythematosus Patients with Periodontal Disease

Abstract

Objectives The aim of the study was to analyze the correlation between periodontitis severity in systemic lupus erythematosus (SLE) with CD4/CD8 lymphocytes ratio and cytomegalovirus gamma immunoglobulin (IgG CMV) level.

Materials and Methods This is a descriptive study using a cross-sectional approach that included 93 subjects who were diagnosed with SLE in Rheumatology Department, Saiful Anwar Hospital, during 2017 to 2019. Periodontitis severity was assessed by periodontal Index (PI). CD4/CD8 lymphocyte ratio was determined using flow cytometry and IgG CMV levels using enzyme-linked immunosorbent assay.

Statistical Analysis The differences among the three groups were analyzed using analysis of variance. Correlation among the groups was calculated using Spearman/Pearson correlation coefficient test, while regression analysis was done using Statistical Package for the Social Sciences.

Results The mean of periodontitis severity and standard deviation in SLE was 2.66 ± 1.02. There were negative correlation between CD4/CD8 lymphocyte ratio with periodontal index (r = –0.971) and positive correlation between IgG CMV level with periodontal index (r = 0.977).

Conclusions Inverted CD4/CD8 ratio and IgG CMV were found associated with periodontitis severity in SLE patient. Further research was recomended that CD4/CD8 lymphocytes ratio and IgG CMV can be used as a potensial marker of periodontitis severity in SLE patients.

Keywords

periodontitis - systemic lupus erythematous - CD4/CD8 ratio - IgG CMV

Publikationsverlauf

Artikel online veröffentlicht:
15. September 2020

• References

• 1 Fabbri C, Fuller R, Bonfá E, Guedes LK, D’Alleva PS, Borba EF. Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy. Clin Rheumatol 2014; 33 (04) 505-509
• 2 Petri M, Orbai AM, Alarcón GS. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64 (08) 2677-2686
• 3 Calderaro DC, Ferreira GA, Corrêa JD. et al. Is chronic periodontitis premature in systemic lupus erythematosus patients?. Clin Rheumatol 2017; 36 (03) 713-718
• 4 Rutter-Locher Z, Fuggle N, Orlandi M, D’Aiuto F, Sofat N. Periodontal disease and autoimmunity: what we have learned from microbiome in rheumatology. J Intech 2017; 6: 127-129
• 5 Kobayashi T, Ito S, Yamamoto K. et al. Risk of periodontitis in systemic lupus erythematosus is associated with Fcgamma receptor polymorphisms. J Periodontol 2003; 74 (03) 378-384
• 6 Gofur NRP, Nurdiana N, Handono K, Kalim H. Periodontal tissue condition on systemic lupus erythematosus patients: a clinical study. Pesqui Bras Odontopediatria Clin Integr 2020; 20 (01) 5094-5102
• 7 Gofur NRP, Nurdiana N, Kalim H, Handono K. Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus. J Taibah Univ Med Sci 2019; 14 (06) 560-565
• 8 Gofur NRP, Nurdiana N, Handono K, Kalim H. Immune aging marker associated with periodontitis in systemic lupus erythematosus patients. AIP Conf Proc 2019; 5 (01) 1-11
• 9 Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough. ? Periodontol 2000 2013; 62 (01) 271-286
• 10 Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013; 62 (01) 59-94
• 11 Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 2013; 62 (01) 203-217
• 12 Ebersole JL, Dawson III DR, Morford LA, Peyyala R, Miller CS, Gonzaléz OA. Periodontal disease immunology: ‘double indemnity’ in protecting the host. J Periodontol 2000; 2013 (62) 163-202
• 13 Marques CP, Maor Y, de Andrade MS, Rodrigues VP, Benatti BB. Possible evidence of systemic lupus erythematosus and periodontal disease association mediated by toll-like receptors 2 and 4. Clin Exp Immunol 2016; 183 (02) 187-192
• 14 Kaur G, Mohindra K, Singla S. Autoimmunity - basics and link with periodontal disease. Autoimmun Rev 2017; 16 (01) 64-71
• 15 Megson E, Fitzsimmons T, Dharmapatni K, Bartold PM. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol 2010; 37 (09) 797-804
• 16 Sete MRC, Figueredo CMS, Sztajnbok F. Periodontitis and systemic lupus erythematosus. Rev Bras Reumatol Engl Ed 2016; 56 (02) 165-170
• 17 Beltrán-Aguilar ED, Eke PI, Thornton-Evans G, Petersen PE. Recording and surveillance systems for periodontal diseases. Periodontol 2000 2012; 60 (01) 40-53
• 18 Rebelo MAB, de Queiroz AC. Gingival indices: state of art. In: Panagakos E. ed. Gingival Diseases. Their Aetiology, Prevention and Treatment. London: IntechOpen; 2011: 41-54 chap. 3
• 19 Ormerod MG. Flow cytometry: a basic introduction. De Novo Journal 2008; 4 (01) 73-85
• 20 Gan SD, Patel KR. Enzyme immunoassay and enzyme-linked immunosorbent assay. J Invest Dermatol 2013; 133 (09) e12
• 21 Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012; 24 (03) 69-71
• 22 Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 2017; 56 (11) 1945-1961
• 23 Wu YD, Lin CH, Chao WC, Liao TL, Chen DY, Chen HH. Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: a nationwide, population-based, case-control study. PLoS One 2017; 12 (10) e0187075
• 24 Al-Mutairi KD, Al-Zahrani MS, Bahlas SM, Kayal RA, Zawawi KH. Periodontal findings in systemic lupus erythematosus patients and healthy controls. Saudi Med J 2015; 36 (04) 463-468
• 25 Albandar JM, Susin C, Hughes FJ. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Periodontol 2018; 89 (Suppl. 01) S183-S203
• 26 Hammoudeh M, Al-Momani A, Sarakbi H, Chandra P, Hammoudeh S. Oral manifestations of systemic lupus erythematosus patients in Qatar: a pilot study. Int J Rheumatol 2018; 2018: 6052326
• 27 Nair S, Faizuddin M, Dharmapalan J. Role of autoimmune responses in periodontal disease. Autoimmune Dis 2014; 2014: 596824
• 28 Kaur G, Grover V, Bhaskar N, Kaur RK, Jain A. Periodontal infectogenomics. Inflamm Regen 2018; 38: 8-25
• 29 Damgaard C, Reinholdt J, Enevold C, Fiehn NE, Nielsen CH, Holmstrup P. Immunoglobulin G antibodies against Porphyromonas gingivalisorAggregatibacter actinomycetemcomitansin cardiovascular disease and periodontitis. J Oral Microbiol 2017; 9 (01) 1374154
• 30 Lee SA, Sinclair E, Hatano H. et al. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One 2014; 9 (02) e89444
• 31 Fonseca RR, Alves ACB, Amanajás TA. et al. Absence of cytomegalovirus in gingivitis and chronic periodontitis in HIV-1 patients in Northern Brazil. Rev Soc Bras Med Trop 2018; 51 (06) 809-812
• 32 Manjarrez-orduño N, Menard LC, Carman JA. A systemic lupus erythematosus endophenotype characterized by increased CD8 cytotoxic signature associates with renal involvement. ImmunoHorizons 2017; 1 (07) 124-132